Understanding Corteva's Fundamentals Before Investing in Stocks

Large-cap Consumer Staples company Corteva has moved 1.6% so far today on a volume of 2,554,080, compared to its average of 3,241,890. In contrast, the S&P 500 index moved -0.0%.

Corteva trades -13.72% away from its average analyst target price of $63.65 per share. The 20 analysts following the stock have set target prices ranging from $54.0 to $69.0, and on average have given Corteva a rating of buy.

If you are considering an investment in CTVA, you'll want to know the following:

  • Corteva's current price is 92.4% above its Graham number of $28.55, which implies that at its current valuation it does not offer a margin of safety

  • Corteva has moved -6.5% over the last year, and the S&P 500 logged a change of 24.7%

  • Based on its trailing earnings per share of 0.99, Corteva has a trailing 12 month Price to Earnings (P/E) ratio of 55.5 while the S&P 500 average is 27.65

  • CTVA has a forward P/E ratio of 15.9 based on its forward 12 month price to earnings (EPS) of $3.46 per share

  • The company has a price to earnings growth (PEG) ratio of 1.41 — a number near or below 1 signifying that Corteva is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 1.55 compared to its sector average of 2.79

  • Corteva, Inc. operates in the agriculture business.

  • Based in Indianapolis, the company has 22,500 full time employees and a market cap of $38.28 Billion. Corteva currently returns an annual dividend yield of 1.2%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.